Sai Parenteral's Limited (NSE:SAIPARENT)

India flag India · Delayed Price · Currency is INR
482.55
-2.65 (-0.55%)
At close: Apr 28, 2026
23.10%
Market Cap 21.32B
Revenue (ttm) 1.63B
Net Income (ttm) 144.54M
Shares Out 44.18M
EPS (ttm) 5.43
PE Ratio 89.03
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 159,329
Average Volume 376,900
Open 481.60
Previous Close 485.20
Day's Range 480.95 - 492.00
52-Week Range 392.00 - 526.30
Beta n/a
RSI 86.67
Earnings Date May 30, 2026

About Sai Parenteral's

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, and dermatology in various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments. The company ... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1988
Employees 296
Stock Exchange National Stock Exchange of India
Ticker Symbol SAIPARENT
Full Company Profile

Financial Performance

In fiscal year 2025, Sai Parenteral's's revenue was 1.63 billion, an increase of 6.08% compared to the previous year's 1.54 billion. Earnings were 144.54 million, an increase of 71.76%.

Financial Statements

News

There is no news available yet.